Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Zofran Melt 4mg oral lyophilisates
0406000S0BBAIAI
|
Zofran | Ondansetron hydrochloride | Central Nervous System | 37 |
|
Zofran 4mg/5ml syrup
0406000S0BBAGAG
|
Zofran | Ondansetron hydrochloride | Central Nervous System | 31 |
|
Zofran Melt 8mg oral lyophilisates
0406000S0BBAJAJ
|
Zofran | Ondansetron hydrochloride | Central Nervous System | 25 |
|
Zofran 8mg tablets
0406000S0BBACAC
|
Zofran | Ondansetron hydrochloride | Central Nervous System | 6 |
|
Zofran 4mg tablets
0406000S0BBABAB
|
Zofran | Ondansetron hydrochloride | Central Nervous System | 2 |
|
Zofran 8mg/4ml solution for injection ampoules
0406000S0BBALAD
|
Zofran | Ondansetron hydrochloride | Central Nervous System | 2 |
|
Zofran Flexi-amp 4mg/2ml solution for injection ampoules
0406000S0BBAEAA
|
Zofran | Ondansetron hydrochloride | Central Nervous System | 2 |
|
Zofran 16mg suppositories
0406000S0BBAHAH
|
Zofran | Ondansetron hydrochloride | Central Nervous System | 1 |
|
Zofran 4mg/2ml solution for injection ampoules
0406000S0BBAKAA
|
Zofran | Ondansetron hydrochloride | Central Nervous System | 1 |
|
Zofran Flexi-amp 8mg/4ml solution for injection ampoules
0406000S0BBAFAD
|
Zofran | Ondansetron hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.